Researchers identified three potential subgroups for geographic atrophy based on genotype and specific fundus features, which could lead to better approaches to treating the disease, according to a speaker at the virtual Association for Research in Vision and Ophthalmology meeting.
“If these results are confirmed, the one-size-treats-all approach for treatment of geographic atrophy may be inappropriate, and clinical trials should consider therapeutic approaches and selection criteria that target particular disease subgroups,” Marc Biarnés-Perez, MPH, PhD, said.
Biarnés-Perez
Uncategorized